CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [RNA-Seq]
Ontology highlight
ABSTRACT: MCF7, T47D, or ZR751 cells were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 and/or Fulvestrant and expression changes were measured via RNA-seq
ORGANISM(S): Homo sapiens
PROVIDER: GSE190160 | GEO | 2022/03/04
REPOSITORIES: GEO
ACCESS DATA